Exoskeleton therapy improves mobility, cognition and brain connectivity in people with MS

A team of multiple sclerosis (MS) experts led a pilot randomized controlled trial of robotic-exoskeleton assisted exercise rehabilitation (REAER) effects on mobility, cognition, and brain connectivity in people with substantial MS-related disability. Their results showed that REAER is likely an effective intervention, and is a promising therapy for improving the lives of those with MS.